Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Depreciation and Depletion: 2019-2022

Historic Depreciation and Depletion for Benitec Biopharma (BNTC) over the last 4 years, with Jun 2022 value amounting to $167,000.

  • Benitec Biopharma's Depreciation and Depletion fell 54.76% to $19,000 in Q3 2023 from the same period last year, while for Sep 2023 it was $121,000, marking a year-over-year decrease of 22.93%. This contributed to the annual value of $167,000 for FY2022, which is 27.71% down from last year.
  • Latest data reveals that Benitec Biopharma reported Depreciation and Depletion of $167,000 as of FY2022, which was down 27.71% from $231,000 recorded in FY2021.
  • Benitec Biopharma's Depreciation and Depletion's 5-year high stood at $231,000 during FY2021, with a 5-year trough of $158,000 in FY2019.
  • In the last 3 years, Benitec Biopharma's Depreciation and Depletion had a median value of $190,000 in 2020 and averaged $196,000.
  • Per our database at Business Quant, Benitec Biopharma's Depreciation and Depletion grew by 21.58% in 2021 and then fell by 27.71% in 2022.
  • Over the past 4 years, Benitec Biopharma's Depreciation and Depletion (Yearly) stood at $158,000 in 2019, then grew by 20.25% to $190,000 in 2020, then grew by 21.58% to $231,000 in 2021, then dropped by 27.71% to $167,000 in 2022.